慢性非感染性腹泻:综述
本综述指出慢性腹泻定义为松散或水样便持续超过4周,美国成人患病率约6%至7%,其中超过90%为非感染性病因。最常见病因为腹泻型肠易激综合征(IBS-D)和功能性腹泻;小肠源性病因(如乳糜泻、小肠细菌过度生长)常伴大量腹泻和体重下降,结肠病变(如胆汁酸性腹泻、显微镜性结肠炎)常表现为频繁少量排便。评估包括乳糜泻血清学(组织转谷氨酰胺酶免疫球蛋白A及总免疫球蛋白A)和粪便钙卫蛋白;有消化道出血、不明原因体重下降、45岁及以上、夜间腹泻、脂肪泻和/或缺铁性贫血者应行结肠镜及上消化道内镜,结肠镜时推荐随机活检以评估显微镜性结肠炎(占慢性腹泻患者的13%)。未明确病因者按IBS-D或功能性腹泻处理,经验性治疗(饮食调整或洛哌丁胺、莨菪碱、双环维林、昂丹司琼)通常可使50%至80%的患者腹泻改善。
要点
- 慢性腹泻定义为松散或水样便持续超过4周,美国成人患病率约6%至7%,超过90%为非感染性病因。
- 有消化道出血、不明原因体重下降、45岁及以上、夜间腹泻、脂肪泻和/或缺铁性贫血者应行结肠镜及上消化道内镜评估结直肠癌。
- 结肠镜时推荐随机活检以评估显微镜性结肠炎,该病影响13%的慢性腹泻患者。
- 评估包括乳糜泻血清学(组织转谷氨酰胺酶免疫球蛋白A及总免疫球蛋白A)和粪便钙卫蛋白以评估炎症性肠病。
- 经验性治疗包括低可发酵寡糖、二糖、单糖及多元醇饮食,或洛哌丁胺、莨菪碱、双环维林、昂丹司琼,通常可使50%至80%的患者腹泻改善。
适用人群与场景
- 慢性腹泻定义为松散或水样便持续超过4周,美国成人患病率约6%至7%,超过90%为非感染性病因。
- 小肠源性病因(如乳糜泻、小肠细菌过度生长)常伴大量腹泻和体重下降,伴或不伴脂肪泻。
- 结肠病变(如胆汁酸性腹泻、显微镜性结肠炎)常表现为频繁少量排便,伴或不伴急迫感和黏液增多。
诊断标准与关键阈值
- 功能性腹泻:前3个月中超过25%的排便为松散或水样便,但不伴有显著腹痛。
- 腹泻型肠易激综合征(IBS-D):反复腹痛,排便后缓解或加重。
- 乳糜泻:遗传易感个体暴露于饮食麸质所诱发的肠病,属自身免疫性疾病。
- 小肠细菌过度生长:小肠内细菌过度增殖。
- 胆汁酸性腹泻:结肠内胆汁酸过多。
- 显微镜性结肠炎:结肠活检显示慢性炎症而内镜下表现正常。
处置流程与药物剂量
- 评估包括乳糜泻血清学(组织转谷氨酰胺酶免疫球蛋白A及总免疫球蛋白A)和粪便钙卫蛋白以评估炎症性肠病。
- 有消化道出血、不明原因体重下降、45岁及以上、夜间腹泻、脂肪泻和/或缺铁性贫血者应行结肠镜评估结直肠癌及上消化道内镜。
- 结肠镜时推荐随机活检以评估显微镜性结肠炎。
- 未明确病因者按IBS-D或功能性腹泻处理,行生活方式调整:规律进餐、运动、每日摄入至少8杯非咖啡因液体、咖啡因限制在每日3杯或以下、避免酒精和碳酸饮料。
- 饮食调整:低可发酵寡糖(豆类、小麦、洋葱、大蒜)、二糖(乳糖)、单糖(果糖)及多元醇(山梨醇、甘露醇)饮食。
- 药物:阿片激动剂(洛哌丁胺)、抗胆碱能药(莨菪碱、双环维林)或5-羟色胺3受体拮抗剂(昂丹司琼)可处方使用。
- 上述治疗通常可使50%至80%的患者腹泻改善。
红旗征与不能漏的情况
- 消化道出血、不明原因体重下降、45岁及以上、夜间腹泻、脂肪泻和/或缺铁性贫血者应行结肠镜及上消化道内镜评估结直肠癌。
研究设计与关键结果
- 综述指出慢性非感染性腹泻最常见病因为IBS-D和功能性腹泻。
- 诊断评估应包括考虑乳糜泻、炎症性肠病和显微镜性结肠炎。
- 显微镜性结肠炎影响13%的慢性腹泻患者,结肠镜时推荐随机活检。
- 经验性治疗(生活方式和饮食调整及阿片激动剂、抗胆碱能药或5-HT3拮抗剂)通常可使50%至80%的患者腹泻改善。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对慢性腹泻患者应常规考虑乳糜泻血清学(组织转谷氨酰胺酶免疫球蛋白A及总免疫球蛋白A)和粪便钙卫蛋白。
- 有消化道出血、不明原因体重下降、45岁及以上、夜间腹泻、脂肪泻和/或缺铁性贫血者应行结肠镜及上消化道内镜。
- 结肠镜时推荐随机活检以评估显微镜性结肠炎。
- 未明确病因者按IBS-D或功能性腹泻处理,给予生活方式和饮食调整及经验性药物(洛哌丁胺、莨菪碱、双环维林、昂丹司琼)。
指南或共识出处
- JAMA
提炼说明
- 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Chronic diarrhea is defined as loose or watery stools lasting longer than 4 weeks and affects approximately 6% to 7% of adults in the US. More than 90% of patients with chronic diarrhea have a noninfectious etiology.
OBSERVATIONS: The most common causes of chronic, noninfectious diarrhea are irritable bowel syndrome with diarrhea (IBS-D) and functional diarrhea. IBS-D typically presents with recurrent abdominal pain relieved or worsened after defecation. Functional diarrhea is a condition in which more than 25% of bowel movements in the preceding 3 months are loose or watery, but it is not associated with significant abdominal pain. Chronic diarrhea due to a small-bowel source, such as celiac disease or small intestinal bacterial overgrowth, is typically associated with large-volume diarrhea and weight loss, with or without steatorrhea. Celiac disease is an autoimmune condition defined by enteropathy precipitated by exposure to dietary gluten in genetically predisposed individuals, and small intestinal bacterial overgrowth is characterized by excessive bacteria in the small bowel. Chronic diarrhea due to colon pathology, such as bile acid diarrhea and microscopic colitis, typically presents with frequent, low-volume stools, with or without urgency and excess mucus. Bile acid diarrhea is characterized by excess bile acids in the colon, and microscopic colitis is characterized by chronic inflammation on colon biopsies despite normal endoscopic appearance. Evaluation of chronic diarrhea includes serological testing for celiac disease (tissue transglutaminase immunoglobulin A, along with total immunoglobulin A) and stool testing for fecal calprotectin to evaluate for inflammatory bowel disease. Patients with gastrointestinal bleeding, unexplained weight loss, 45 years or older, nocturnal diarrhea, steatorrhea, and/or iron deficiency anemia should undergo colonoscopy to evaluate for colorectal cancer as well as upper endoscopy. During colonoscopy, random biopsies are recommended to evaluate for microscopic colitis, which affects 13% of patients with chronic diarrhea. If evaluation does not identify a cause of chronic diarrhea, likely diagnoses are IBS-D or functional diarrhea and the patient should be treated with lifestyle modification, such as regularly scheduled meals, exercise, intake of at least 8 cups of noncaffeinated fluids daily, limiting caffeine to 3 cups or fewer daily, and avoiding alcohol and carbonated beverages. For general treatment of chronic diarrhea, dietary modifications, such as consuming a diet low in fermentable oligosaccharides (legumes, wheat, onions, garlic), disaccharides (lactose), and monosaccharides (fructose), and polyols (sorbitol, mannitol), or medications, such as opiate agonists (loperamide), anticholinergics (hyoscyamine, dicyclomine), or 5-hydroxytryptamine 3 receptor (5-HT3) antagonists (ondansetron), can be prescribed. These therapies typically improve diarrhea in 50% to 80% of patients.
CONCLUSIONS AND RELEVANCE: The most common causes of chronic, noninfectious diarrhea include IBS-D and functional diarrhea. Diagnostic testing should include consideration of celiac disease, inflammatory bowel disease, and microscopic colitis. Empiric therapies for chronic diarrhea include lifestyle and dietary modifications and medications, including opiate agonists, anticholinergics, and 5-HT3 antagonists.
参考来源
- Singh P, Lee A, Sheth NM, et al. Chronic, Noninfectious Diarrhea: A Review. JAMA. 2026. PMID: 41770539. doi:10.1001/jama.2026.0872
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。